L-Glutamic acid, N-[3-bromo-5-chloro-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
|
|
L-Glutamic acid, N-[3-bromo-5-chloro-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- Eigenschaften
- Dichte
- 1.753±0.06 g/cm3(Predicted)
- pka
- 3.44±0.10(Predicted)
Sicherheit
L-Glutamic acid, N-[3-bromo-5-chloro-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- Chemische Eigenschaften,Einsatz,Produktion Methoden
L-Glutamic acid, N-[3-bromo-5-chloro-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
L-Glutamic acid, N-[3-bromo-5-chloro-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 1)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
TargetMol Chemicals Inc. | |
support@targetmol.com | United States | 38631 | 58 |
- L-Glutamic acid, N-[3-bromo-5-chloro-4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-
- Bromochloromethotrexate
- NSC 98579
- NSC98579
- NSC-98579
- 6914-12-1
- C20H20BrClN8O5